Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00075036 · ClinicalTrials.gov registry record

Patient-Provider Trust Among Individuals With End-Stage Kidney Disease

A clinical trial, sponsored by National Institutes of Health Clinical Center (CC).

Completed
Registry status
113
Enrollment target

NCT00075036: Completed study, sponsored by National Institutes of Health Clinical Center (CC).

NCT00075036 is a clinical trial that has completed, run by National Institutes of Health Clinical Center (CC). The registered enrollment target is 113 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00075036 has completed, sponsored by National Institutes of Health Clinical Center (CC).

COMPLETED
Registry status
113 participants
Enrollment target

Study Summary

This study will examine communication and trust between patients in the kidney transplant process and their health care providers. It will assess patients' perception of trust in their physician and nurse coordinator; determine the patients' level of trust in the areas of competence, compassion, control, communication, and confidentiality; and determine how the trust level varies as patients progress in the transplant process. Patients 18 years of age and older who are in various stages of the kidney transplant process at Walter Reed Army Medical Center and the NIH Clinical Center may be eligible for this study. Candidates include individuals who: * are on dialysis but not on a transplant waiting list * are on the organ waiting list and are also on dialysis * are on the organ waiting list but are not on dialysis * have had a kidney transplant within the last year. Participants will be interviewed by someone who is not their direct health care provider about the doctor/patient, primary provider/patient, or nurse/patient relationship, their health history, medical condition, and ideas about their care. With the patient's permission, parts of the interview will be tape-recorded. The interview will take about 30 to 40 minutes.

Trial Details

FieldValue
Enrollment Target 113 participants
Start Date 2004-02-27
Est. Completion 2019-09-13

What the finished NCT00075036 record still lists

NCT00075036 is an observational study that tracks outcomes without assigning an intervention. The registered 113 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT00075036 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00075036 about?

NCT00075036 is a clinical study titled "Patient-Provider Trust Among Individuals With End-Stage Kidney Disease". This study will examine communication and trust between patients in the kidney transplant process and their health care providers. It will assess patients' perception of trust in their physician and nurse coordinator; determine the patients' level of trust in the areas of competence, compassion, con...

What is the current status of trial NCT00075036?

This trial is currently completed. The enrollment target is 113 participants. The study started on 2004-02-27. Estimated completion is 2019-09-13.

Who is sponsoring clinical trial NCT00075036?

This trial is sponsored by National Institutes of Health Clinical Center (CC), which has 338 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00748254 · 113 participants

    Laser-based Photoacoustic Tomography of Human Inflammatory Arthritis

  • NCT04753190 · 113 participants · NA

    Light Timing Study

  • NCT05799248 · 113 participants · Phase 3

    Role of rhPSMA-7.3 PET/CT Imaging in Men With High-Risk Prostate Cancer Following Conventional Imaging and Associated Changes in Medical Management

  • NCT07216105 · 113 participants · Phase 1

    FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT00075036, the US trial registry maintained by the National Library of Medicine. NCT00075036 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.